Are animal models useful or confusing in understanding the human feto-maternal relationship? A debate

Journal of Reproductive Immunology

Volumn 108, Issue , 2015, Pages 56-64

  Chaouat, Gérard ^a   Clark, David A ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Animal models; Pregnancy immunology

Indexed keywords

ARTICLE; CHROMOSOME 19; HUMAN; IMMUNOTHERAPY; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NONHUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRENATAL GROWTH; PRIORITY JOURNAL; RECURRENT ABORTION; STRUCTURAL HOMOLOGY; TROPHOBLAST; ANIMAL; ANIMAL MODEL; CONSENSUS DEVELOPMENT; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; MALE; MOUSE; PHYSIOLOGY; SPECIES DIFFERENCE; SPONTANEOUS ABORTION;

HLA ANTIGEN;

ABORTION, SPONTANEOUS; ANIMALS; FEMALE; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MALE; MATERNAL-FETAL EXCHANGE; MICE; MODELS, ANIMAL; PLACENTA; PREGNANCY; SPECIES SPECIFICITY;

EID: 84926261144     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2014.10.004     Document Type: Article

References (88)

1. Abi-Rached L., Kuhl H., Roos C., ten Hallers B., Zhu B., Carbone L., et al. A small, variable, and irregular killer cell Ig-like receptor locus accompanies the absence of MHC-C and MHC-G in gibbons. J. Immunol. 2010, 184:1379-1391.
2. Abi-Rached L., Moesta A.K., Rajalinghiam R., Guethien L.A., Parham P. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. PLoS Genet. 2010, 6:e1001192.
3. Ahmed A., Singh J., Khan Y., Seshan S.V., Girardi G. A new mouse model to explore therapies for preeclampsia. PLoS ONE 2010, 5:e13663.
4. Antczak D.F., Allen W.R. Maternal immunological recognition of pregnancy in equids. J. Reprod. Fertil. 1989, 37(Suppl.):69-78.
5. Arck P.C. Understanding reproductive immunology: implications outside the objective of receiving a 'take home' baby. J. Reprod. Immunol. 2014, 101-102:6-7.
6. Arnaiz-Villena A., Martinez-Laso J., Castro M.J., Morales P., Moscoso J., et al. The evolution of the MHC-G gene does not support a functional role for the complete protein. Immunol. Rev. 2001, 183:65-75.
7. Arnaiz-Villena A., Martinez-Laso J., Serrano-Vela J.I., Reguera R., Moscoso J. HLA-G polymorphism and evolution. Tissue Antigens 2007, 69(Suppl. 1):156-159.
8. Bailey C.M., Morrison J.A., Kulesa P.M. Melanoma revives an embryonic migration program to promote plasticity and invasion. Pigment Cell Melanoma Res. 2012, 25:573-583.
9. Barten R., Torkar M., Haude A., Trowsdale J., Wilson M.J. Divergent and convergent evolution of NK-cell receptors. Trends Immunol. 2001, 22:52-57.
10. Bazer F.W. Contributions of an animal scientist to understanding the biology of the uterus and pregnancy. Reprod. Fertil. Dev. 2012, 25:129-147.
11. Bazrgar M., Gourabi H., Valojerdi M.R., Yazdi P.E., Baharvand H. Self-correction of chromosomal abnormalities in human preimplantation embryos and embryonic stem cells. Stem Cells Dev. 2013, 22:2449-2456.
12. Bell S.C., Billington W.D. Anti-fetal allo-antibody in the pregnant female. Immunol. Rev. 1983, 75:5-30.
13. Billington W.D. The normal fetomaternal immune relationship. Baillieres Clin. Obstet. Gynaecol. 1992, 6:417-438.
14. Billington W.D., Burrows F.J. The rat placenta expresses paternal class I major histocompatibility antigens. J. Reprod. Immunol. 1986, 9:155-160.
15. Bondarenko G.I., Burleigh D.W., Durning M., Breburda E.E., Grendell R.L., Golos T.G. Passive immunization against the MHC class I molecule Mamu-AG disrupts rhesus placental development and endometrial responses. J. Immunol. 2007, 179:8042-8050.
16. Boudakov I., Liu J., Fan N., Gulay P., Wong K., Gorczynski R.M. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200. Transplantation 2007, 84:251-257.
17. Boyson J.E., Iwanaga K.K., Golos T.G., Watkins D.I. Identification of the rhesus monkey HLA-G ortholog. Mamu-G is a pseudogene. J. Immunol. 1996, 157:5428-5437.
18. Castro M.J., Morales P., Martinez-Laso J., Allende L., Rojo-Amigo R., Gonzalez-Hevilla M., et al. Lack of MHC-G4 and soluble (G5, G6) isoforms in the higher primates, Pongidae. Hum. Immunol. 2000, 61:1164-1168.
19. Chaline J. Increased cranial capacity in hominid evolution and preeclampsia. J. Reprod. Immunol. 2003, 59:137-152.
20. Chaouat G. Are there abortions of immunological origin? Part A: animal models of spontaneous immunological abortion. Immunology of Pregnancy 2013 2013, 649-675. Bentham Science Publishers, Saif Zone Sharjah, U.A.E. B. Chaouat, S. Olivier, N. Ledee (Eds.).
21. Chen T., Darrasse-Jeze G., Bergot A.-S., Courau T., Churland G., Valdivia K., et al. Self-specific memory regulatory T cells protect embryos at implantation in mice. J. Immunol. 2013, 191:2273-2281.
22. Cheng Y.N., Wu X.C., Ji Q. Triassic marine reptiles gave birth to live young. Nature 2004, 432:383-386.
23. Clark D.A. Controversies in reproductive immunology. Crit. Rev. Immunol. 1991, 11:215-247.
24. Clark D.A. Is there any evidence for immunologically-mediated or immunologically-modifiable early pregnancy failure?. J. Assist. Reprod. Genet. 2003, 20:63-72.
25. Clark D.A. The use and misuse of animal models of human pregnancy disorders. J. Reprod. Immunol. 2014, 103:1-8.
26. Clark D.A., Chaouat G. Regulatory T cells and reproduction: how do they do it?. J. Reprod. Immunol. 2012, 96:1-7.
27. Clark D.A., Manuel J., Lee L., Chaouat G., Gorczynski R.M., Levy G.A. Ecology of danger-dependent cytokine-boosted spontaneous in the CBA×DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-α+IFN-γ) on pregnancy loss. Am. J. Reprod. Immunol. 2004, 52:370-387.
28. Clark D.A., Petitbarat M., Chaouat G. How should data on murine spontaneous abortion rates be expressed and analysed?. Am. J. Reprod. Immunol. 2008, 60:192-196.
29. Clark D.A., Rahmati M., Bensussan A., Markert U.R., Chaouat G. Seminal plasma peptides may determine maternal immune response that alters success or failure of pregnancy in the abortion-prone CBAxDBA/2 model. J. Reprod. Immunol. 2013, 99:46-53.
30. Clark D.A., Dhesy-Thind S., Ellis P., Ramsay J. The CD200-tolerance signaling molecule associated with pregnancy success is present in patients with early-stage breast cancer but does not favor nodal metastasis. Am. J. Reprod. Immunol. 2014, 72:435-439.
31. Collins J.A. Preimplantation genetic screening in older mothers. N. Engl. J. Med. 2007, 357:9-17.
32. Crosley E.J., Elliot M.G., Christians J.K., Crespi B.J. Placental invasion, preeclampsia risk and adaptive molecular evolution at the origin of the great apes: evidence from genome-wide analyses. Placenta 2013, 34:127-132.
33. Croy B.A., Wessels J.M., Linton N.F., van den Heuvel M., Edwards A.K., Tayade C. Cellular and molecular events in early and mid gestation porcine implantation sites: a review. Soc. Reprod. Fertil. Suppl. 2009, 66:233-244.
34. Croy B.A., Wessels J., Linton N., Tayade C. Comparison of immune cell recruitment and function in endometrium during development of epitheliochorial (pig) and hemochorial (mouse and human) placentas. Placenta 2009, (Suppl. A):S26-S31.
35. hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J. Clin. Invest. 2009, 119:2648-2662.
36. de Mestre A., Noronha L., Wagner B., Antczak D.F. Split immunological tolerance to trophoblast. Int. J. Dev. Biol. 2010, 54:445-455.
37. Ferry B.L., Sargent I.L., Starkey P.M., Redman C.W.G. Cytotoxic activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from human early pregnancy deciduas. Cell. Immunol. 1991, 132:140-149.
38. Fragouli E., Escalona A., Gutierrez-Mateo C., Tormasi S., Alfarawati S., Sepulveda S., et al. Comparative genomic hybridization of oocytes and first polar bodies from young donors. Reprod. Biomed. Online 2009, 19:228-237.
39. Gorczynski R.M., Chen Z., Diao J., Khatri I., Wong K., Yu K., et al. Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice. Breast Cancer Res. Treat. 2010, 123:405-415.
40. Gorczynski R.M., Clark D.A., Erin N., Khatri I. Role of CD200 in regulation of metastasis of EMT6 tumor cells in mice. Breast Cancer Res. Treat. 2011, 130:49-60.
41. Gorczynski R.M., Chen Z., Khatri I., Podnos A., Yu K. Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling. Breast Cancer Res. Treat. 2013, 142:271-282.
42. + T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: implications for immunotherapy. BMC Cancer 2008, 8:57-68.
43. + cell pool and CCL19-mediated recruitment. Biol. Reprod. 2011, 85:397-408.
44. Haines A.N., Flajnik M.F., Wourms J.P. Histology and immunology of the placenta in the Atlantic sharpnose shark, Rhizoprionodon terraenovae. Placenta 2006, 27:1114-1123.
45. Hamilton W.J., Boyd J.D., Mossman H.W. Human Embryology 1962, Heffer & Sons Ltd., Cambridge, UK. 3rd ed.
46. Hedley M.L., Drake B.L., Head J.R., Tucker P.W., Forman J. Differential expression of the class I MHC genes in the embryo and placenta during midgestational development in the mouse. J. Immunol. 1989, 142:4046-4053.
47. Hepworth M.R., Sonnenberg G.F. Regulation of the adaptive immune system by innate lymphoid cells. Curr. Opin. Immunol. 2014, 27:75-82.
48. Hewitt H.B., Blake E.R., Walder A.S. A critique of the evidence for active host defence against cancer based on personal studies of 27 murine tumors of spontaneous origin. Br. J. Cancer 1976, 33:241-249.
49. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004, 200:957-965.
50. Hiby S.E., Apps R., Sharkey A.M., Farrell L.E., Gardner L., Mulder A., et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 2010, 120:4102-4110.
51. Hiby S.E., Apps R., Chazara O., Farrell L.E., Magnus P., Trogstad L., et al. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J. Immunol. 2014, 192:5069-5073.
52. Hirte H., Clark D.A. Generation of lymphokine-activated killer cells (LAK) in human ovarian carcinoma ascitic fluid: identification of TGF-β as a suppressive factor. Cancer Immunol. Immunother. 1991, 32:296-302.
53. Jiang W., Johnson C., Jayaraman J., Simecek N., Noble J., Moffett M.F., et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res. 2012, 22:1845-1854.
54. Langat D.K., Hunt J.S. Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G?. Biol. Reprod. 2002, 67:1367-1374.
55. Liu J., Wang W., Sun X., Liu L., Li M., Witz C., et al. DNA microarray reveals that a high proportion of human blastocysts from women of advanced maternal age are aneuploid and mosaic. Biol. Reprod. 2012, 87:148.
56. Loke Y.W., King A. Immunology of implantation. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 2000, 14:827-837.
57. Long J.A., Trinajstic K., Young G.C., Senden T. Live birth in the Devonian period. Nature 2008, 453:650-652.
58. Makrigiannis A.P., Anderson S.K. Ly49 gene expression in different inbred mouse strains. Immunol. Res. 2000, 21:39-47.
59. Markert U.R., Ospina-Prieto S., Chaiwangyen W., Schmidt A., Morales-Prieto D.M. Only humans have human placentas. J. Reprod. Immunol. 2014, 101-102:10.
60. Martal J.L., Chêne N.M., Huynh L.P., L'Haridon R.M., Reinaud P.B., Guillomot M.W., et al. IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 1998, 80:755-777.
61. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
62. Medawar P.B. Advice to a Young Scientist 1979, Harper and Row, New York.
63. Moffett A., Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006, 6:584-594.
64. Moffett A., Hiby S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum. Reprod. 2009, 8:2048-2949.
65. Moreau J., Veyrune J.L., Reme T., De Vos J., Klein B. CD200: a putative therapeutic target in cancer. Biochem. Biophys. Res. Commun. 2008, 366:117-122.
66. Munne S., Ary J., Zouves C., Escudero T., Barnes F., Cinioglu C., et al. Wide range of chromosome abnormalities in the embryos of young egg donors. Reprod. Biomed. Online 2006, 12:340-346.
67. Naicker T., Khedun S.M., Moodley J., Pijnenborg R. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet. Gynecol. Scand. 2003, 82(8):722-729.
68. National Institutes of Health. Use of Chimpanzees in NIH-Supported Research, https://dpcpsi.nih.gov/council/chimpanzee_research.
69. O'Keefe F.R., Chiappe L.M. Viviparity and K-selected life history in a Mesozoic marine plesiosaur (Reptilia, Sauropterygia). Science 2011, 333:870-873.
70. Patel R., Bélanger S., Tai L.H., Troke A.D., Makrigiannis A.P. Effect of Ly49 haplotype variance on NK cell function and education. J. Immunol. 2010, 185:4783-4792.
71. Pierce G.B., Agullar D., Hood G., Wells R.S. Tropectoderm in control of murine embryonal carcinoma. Cancer Res. 1984, 44:3987-3994.
72. Pijnenborg R., Vercruysse L., Carter A.M. Deep trophoblast invasion and spiral artery remodelling in the placental bed of the chimpanzee. Placenta 2011, 32:400-408.
73. Pijnenborg R., Vercruysse L., Carter A.M. Deep trophoblast invasion and spiral artery remodelling in the placental bed of the lowland gorilla. Placenta 2011, 32:586-589.
74. Podnos A., Clark D.A., Erin N., Yu K., Gorczynski R.M. Further evidence for a role for human CD200 expression in breast cancer metastases in CD200R1KO mice. Breast Cancer Res. Treat. 2012, 136:117-127.
75. Pradeu T., Jaeger S., Vivier E. The speed of change: towards a discontinuity theory of immunity?. Nat. Rev. Immunol. 2013, 13:764-769.
76. + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 2009, 80:1036-1045.
77. Rosenberg S.A. Progress in human tumor immunology and immunotherapy. Nature 2001, 2411:380-384.
78. Samstein R.M., Josefowicz S.Z., Arvey A., Treuting P.M., Rudensky A.Y. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012, 150:29-38.
79. Santos M.A., Teklenburg G., Macklon N.S., Van Opstal D., Schuring-Blom G.H., Krijtenburg P.J., et al. The fate of the mosaic embryo chromosomal constitution and development of day 4, 5 and 8 human embryos. Hum. Reprod. 2010, 25:1816-1926.
80. Scott O.C.A. Tumor transplantation and tumor immunity: a personal view. Cancer Res. 1991, 51:757-763.
81. Smith R.N., Sternlicht M., Butcher G.W. The alloantibody response in the allogeneically pregnant rat. I. The primary and secondary responses and detection of Ir gene control. J. Immunol. 1982, 129:771-776.
82. Sternberg-Simon M., Brodin P., Pickman Y., Onfelt B., Kärre K., Malmberg K.J., et al. Natural killer cell inhibitory receptor expression in humans and mice: a closer look. Front. Immunol. 2013, 4:65.
83. Sznol M., Chen L. Antagonistic antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin. Cancer Res. 2013, 19:1021-1034.
84. Tafuri A., Alferink J., Moller P., Hammerling G.J., Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995, 270:630-633.
85. Talebian F. CD200-CD200R Interaction in Tumor Immunity 2012, (Ph.D. thesis), Ohio State University.
86. Verlinsky Y., Kuliev A. Clinical application of polar body biopsy. Textbook of Assisted Reproductive Technologies 2004, 371-379. Informa Healthcare, London, UK. D.K. Gardner, A. Weissman, C.M. Howles, Z. Shoham (Eds.).
87. Xiong S., Sharkey A.M., Kennedy P.R., Gardner L., Farrell L.E., Farrell L.E., et al. Maternal uterine NK cell-activating receptor K1R2DS1 enhances placentation. J. Clin. Invest. 2013, 123:4264-4272.
88. Yu G., Sun Y., Foerster K., Manuel J., Molina H., Levy G.A., Gorczynski R.M., Clark D.A. LPS-induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule. Am. J. Reprod. Immunol. 2008, 60:135-140.